Canna Law Blog

JANUARY 22, 2020

The company is also running a phase IIb clinical trial of its patented formulation, COMP360, which we covered in a blog post back in 2018. In that post, I explained how the Food and Drug Administration (FDA) approval process works and why this trial is so interesting and important. Denver Decriminalizes Psilocybin.

Clinical Trials 117

Clinical Trials Decriminalization Microdosing Food 117

Cannabis Law Report

JULY 1, 2021

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is engaged in a three-year initiative to examine the ethical, legal, and social implications of psychedelics research, commerce, and therapeutics. While psychedelic therapies make their way through the drug development pipeline, seven U.S.

Law 59

Law Policy Research and Development Clinical Trials 59

SpeedWeed

JULY 6, 2021

Harvard Law School is planning to open the first US policy center focused on the legalization and regulation of psychedelics like psilocybin, MDMA, and LSD. . By analyzing social, legal, and political barriers to access in this context, we hope to advance the understanding of their potential impact as therapeutics.”.

Policy 52

Policy Law Research and Development Therapy 52

Cannabis Law Report

MAY 29, 2022

7] And cities around the country are beginning to decriminalize some psychedelics, with advocates for decriminalization citing the potential medical benefits. In May 2019, Denver became the first city to decriminalize psilocybin, followed by Oakland, CA, Washington, D.C., Clinical Trials and Human Subject Protections.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

JUNE 29, 2021

Synergetic Press and the Multidisciplinary Association for Psychedelic Science (MAPS) are pleased to announce they have entered into a copublishing relationship effective May 1, 2021 which will greatly expand the availability of education about psychedelics and psychedelic therapy.

Therapy 90

Therapy Research and Development Clinical Trials Education 90

NORML

JANUARY 18, 2019

House lawmakers introduced The Medical Cannabis Research Act of 2019 (HR 601), to facilitate federally-approved clinical trials involving cannabis. Meanwhile, a decriminalization bill was defeated in the Virginia House this week. Click here to email your lawmakers in support of legalization. Virgin Islands. CT resident?

Legislation 163

Legislation Decriminalization Access Therapy 163

Canna Law Blog

OCTOBER 8, 2020

Oregon Psychedelics: Petition to Legalize Psilocybin for Therapy Moves Forward. For one, research on the benefits of psilocybin therapy in treating depression is farther along than most people think; the results are quite promising ; and more clinical trials are underway, including at esteemed research institutions like Johns Hopkins.

Research and Development 53

Research and Development Decriminalization Clinical Trials Therapy 53

Cannabis Law Report

MARCH 2, 2020

The global march toward cannabis legalization has seemingly awoken another long dormant area of scientific interest: psychedelics as medicine. Food and Drug Administration (FDA) granted Breakthrough Therapy designation (BTD) to Compass Pathways ‘ psilocybin therapy for treatment-resistant depression. In 2018, the U.S.

Medicine 59

Medicine Therapy DEA Pharmaceutical 59

The Cannigma

AUGUST 31, 2021

The researchers stated that these knowledge gaps must be addressed and that “clinical trial data about how medical cannabis improves patient quality of life domains is desperately needed as this information can impact clinical decision-making.”. The survey also found that 89.5%

Education 101

Education Clinical Trials Medicine Policy 101

Veriheal

JUNE 29, 2021

In the last 100 years, many of the plant therapies that were embraced in history were outlawed by governments around the world and replaced by lab-made synthetic drugs we label medicine. It wasn’t until the last several hundred years that how we could heal our bodies became regulated by government entities. A Push by Patients.

Therapy 55

Therapy DEA Patients Clinical Trials 55

NewsMunchies

DECEMBER 13, 2021

In the largest clinical trial to date, a new study conducted by the UK-based pharmaceutical company Compass Pathways shows that psilocybin or “magic” mushrooms can safely relieve depression. The trial included 233 patients from 10 countries in North America and Europe. Food and Drug Administration.

Clinical Trials 95

Clinical Trials Therapy Decriminalization Patients 95

Canna Law Blog

MARCH 4, 2020

In an even larger trend, the health care provider community seems to be exploring various alternative therapies and emerging medicines to improve quality of care. Recently, the decriminalization of psilocybin (by various cities) has been in the news as an emerging medicine. What are the exact legalities behind ketamine?

Therapy 90

Therapy Legalization Chronic Pain DEA 90

Canna Law Blog

NOVEMBER 6, 2021

But despite increasing acceptance by the public, and commercial investment in psychedelic therapies, aging federal laws stem the flow of vital research. Instead, qualifying evidence may come from adequate and well-controlled clinical trials. Phase I trials should be sufficient, and many have been completed using psilocybin.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

Canna Law Blog

MARCH 4, 2020

In an even larger trend, the health care provider community seems to be exploring various alternative therapies and emerging medicines to improve quality of care. Recently, the decriminalization of psilocybin (by various cities) has been in the news as an emerging medicine. What are the exact legalities behind ketamine?

Legalization 52

Legalization Therapy Chronic Pain DEA 52

Cannabis Law Report

SEPTEMBER 10, 2019

Upcoming studies will determine the effectiveness of psilocybin as a new therapy for opioid addiction, Alzheimer’s disease, post-traumatic stress disorder (PTSD), post-treatment Lyme disease syndrome (formerly known as chronic Lyme disease), anorexia nervosa and alcohol use in people with major depression.

Research and Development 45

Research and Development Microdosing Clinical Trials Decriminalization 45

Cannabis Law Report

AUGUST 7, 2022

In recent years, as more clinical trial results show that psychedelics can be used in conjunction with therapy to treat illnesses like depression and post-traumatic stress disorder, legislators pushed to make certain substances available in certain settings. But these substances remain illegal under federal law.

Law 74

Law Research and Development Therapy Treatment 74

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Andrew is a supporter of legalizing psychedelic drugs and has been vocal about his intentions if he were to assume a government office.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

DECEMBER 30, 2019

Illinois and the US territory of Guam legalized adult-use cannabis and its retail sale, medical cannabis programs were enacted and expanded in several states, and 27 states considered legislation that would have legalized adult-use cannabis, a record-high. Continued Protections for State Legal Medical Programs. Erik Altieri.

Legislation 59

Legislation Patients Access Banking 59